MEETING AT A GLANCE
http://www.ispor.org/meetings/washington0505/index.asp
EXHIBIT SPACE, contract available online at
https://www.ispor.org/Exhibit_Sponsor/ExhibitorOpportunities.aspx?event=2
SPONSORSHIP Opportunities are available, for more information
go to
https://www.ispor.org/Exhibit_Sponsor/SponsorshipOpportunities.aspx?event=2
- EDUCATION ACTIVITIES
Top
**NEW** ISPOR
SHORT COURSES
Saturday,
May 14th & Sunday May 15th, 2005 - Prior to the ISPOR 10th Annual International Meeting
**For short course
descriptions and faculty information go to:
Saturday, May 14th:
http://www.ispor.org/meetings/washington0505/sc14.asp
Sunday, May 15th:
http://www.ispor.org/meetings/washington0505/sc15.asp
Pharmacoeconomics Courses:
Pharmacoeconomics for Decision-makers – Saturday Full Day Course
(8:00am-5:00pm)
Elements of
Pharmaceutical Pricing – Sunday Morning Course (8:00am-12:00pm)
Clinical Assessment Courses:
Retrospective Database Analysis: Data sources and Methods – Saturday Full
Day Course (8:00am-5:00pm)
Meta-Analysis and Systematic Literature Review –
Sunday Morning Course (8:00am-12:00pm)
Modeling Courses:
Bayesian Analysis: Overview – Saturday Morning
Course (8:00am-12:00pm)
Bayesian Analysis: Applications – Saturday Afternoon
Course (1:00pm-5:00pm)
Modeling: Structure & Design of Model – Sunday Full Day Course
(8:00am-5:00pm)
Discrete
Event Simulation for Economic Analyses - Sunday Afternoon Course
(1:00pm-5:00pm)
Introduction
to Decision Analysis
–
Sunday Afternoon Course (1:00pm-5:00pm)
Quality of Life/Patient-reported Outcomes Courses:
Introduction
to Quality of Life/Patient-Reported Outcomes – Saturday Afternoon Course
(1:00pm-5:00pm)
Old and New Utility
Measures in Health Economics and Outcomes Research – Sunday
Morning Course
(8:00am-12:00pm)
Advanced
Quantitative Methods for Quality of Life/Patient-reported Outcomes Research – Sunday Afternoon Course (1:00pm-5:00pm)
Economic Analysis Courses:
Financial
Impact / Cost of Illness – Saturday Afternoon Course (1:00pm-5:00pm)
Cost Estimation:
Finding and Extracting Cost Data – Sunday Morning Course (8:00am-12:00pm)
Statistical
Considerations in Economic Evaluations – Sunday Afternoon Course
(1:00pm-5:00pm)
**COMING THIS MONTH** NEW ISPOR Distance Learning Program Modules
http://www.ispor.org/distancelearning/index.asp
Modules on the
Pharmacoeconomics
in Drug Development, Reimbursement and Marketing
·
Pharmacoeconomics
in Drug Development and Marketing: An Overview
·
Drug Development
- Pre-Phase II Pharmacoeconomic Activities
·
Drug
Development- Phase II Pharmacoeconomic Activities
·
Drug Development
– Phase III Pharmacoeconomic Activities
·
Drug Development
– Phase IIIB and Pre-Market Entry Pharmacoeconomic Activities
The following module topics are currently available:
Pharmacoeconomics
Pharmacoeconomic Evaluations & Methods
Cost-Effectiveness
Analysis
Cost-Benefit
Analysis
Cost-Utility
Analysis
Humanistic
Outcomes (Utilities, Health-related Quality of Life, Patient-reported Outcomes,
Patient Preferences)
Study Design in
Pharmacoeconomics
Guidelines
and Reference Standards
- STUDENT NEWS
Top
Visit ISPOR Internship- Professional Recruitment
Assistance Program (I-PRAP)
http://www.ispor.org/iprap/index.asp
STUDENTS have the opportunity to search for internship positions available and post their
CVs/resumes for employers to view. Post your CV today!
EMPLOYERS have the opportunity to access CVs/resumes from interested
students.
For more details on the ISPOR Student Network, please
visit:
http://www.ispor.org/student/student_index.asp
- ISPOR SPECIAL INTEREST GROUPS (SIG)
Top
MEDICATION COMPLIANCE SIG
**NEW** Medication Compliance SIG – Consensus Definitions for
Medication Compliance/Adherence and Medication Persistence
Consensus definition of key terms will have a considerable
impact on effective outcomes research. The Issues and Definitions Workgroup,
chaired by Peter Wong have proposed draft consensus definitions for Medication
Compliance/Adherence and Medication Persistence. View the definitions and give
your comments –
http://www.ispor.org/surveys/MedComp/default.asp.
Deadline December 20th 2004
**NEW**Medication Compliance SIG – New Chair for Economics of
Compliance Working Group
Dyfrig Hughes, PhD (Senior Research Fellow in Pharmacoeconomics and
Director, Centre for the Economics of Health, University of Wales, Bangor) is welcomed as the new
chair of the ECON Working Group. Leadership and Reference group members are
needed. E-mail interest to
medcompsig@ispor.org
For more details on
this SIG, please visit:
http://www.ispor.org/sigs/medication.asp
PATIENT REGISTRY SIG
**NEW** Patient Registry SIG Survey
The
Patient Registry SIG Survey results are currently being compiled. Over 300
ISPOR members participated in the survey.
For more details on this SIG, please visit:
http://www.ispor.org/sigs/patient_registr.asp
RETROSPECTIVE DATABASE SIG
**NEW** New Working Group Selected
This SIG is under new leadership.
The new Working Groups are:
·
Classification
of Databases
·
Policy Advocacy
·
Research
Design & Analysis
·
Database
Development
·
Privacy
Regulations
If you would like to participate, e-mail your interest,
working group, and leadership interest to
rdsig@ispor.org.
For more details on this SIG, please visit:
http://www.ispor.org/sigs/retrospective_db.asp
QUALITY OF LIFE SIG
**COMING SOON** Cultural &
Translational
Adaptation Task Force Paper
The QOL SIG Cultural & Translational Adaptation Task
Force Paper, “Principles of Good Practice for the Translation and Cultural
Adaptation Process for Patient Reported Outcomes (PRO) Measures: Report of the
ISPOR Task Force for Translation and Cultural Adaptation,” will appear in Value
in Health, Volume 8, Issue 2, available in April 2005.
For more details on this SIG, please visit:
http://www.ispor.org/sigs/qol.asp
HEALTH TECHNOLOGY ASSESSMENT SIG
For more details on this SIG, please visit
http://www.ispor.org/sigs/hta.asp
RISK MANAGEMENT SIG
**NEW** Medication Risk-Benefit Survey
A medication risk-benefit survey is
currently being developed.
For more details on this SIG, please visit:
http://www.ispor.org/sigs/rm.asp
MANAGED
CARE SIG
For more details, please visit
http://www.ispor.org/sigs/mc_pbm.asp
CLINICAL PRACTICE SIG
For more details, please visit:
http://www.ispor.org/sigs/cp.asp
Special
Interest Group membership is open to ALL ISPOR members. To JOIN
any SIG:
http://www.ispor.org/sigs/joinsig.asp
- ISPOR BOARD, COMMITTEE, AND TASK FORCE ACTIVITIES
Top
ISPOR
2005-2006 BOARD OF DIRECTORS CALL FOR NOMINATIONS
ISPOR is a member-driven organization. As a member-driven
organization, its governance is determined by the membership. The ISPOR
Nominations Committee is seeking qualified candidates for the position of
PRESIDENT-ELECT and 2 DIRECTOR positions.
You, as an ISPOR member, are invited to submit your name if
you wish to be considered for a position on the ISPOR BOARD OF DIRECTORS. You
may also recommend the name of another ISPOR member. Please email your
interest or recommendation to:
nominations@ispor.org.
Please attach a curriculum vitae. The deadline for submitting
nominations is Monday, February 2, 2005.
AWARD COMMITTEE ACTIVITIES
**NEW** ISPOR AVEDIS DONABEDIAN OUTCOMES RESEARCH LIFETIME
ACHIEVEMENT AWARD
The ISPOR Awards Committee is seeking nominees for the ISPOR
Avedis Donabedian Outcomes Research Lifetime Achievement Award.
See
http://www.ispor.org/awards/donabedian_.asp
For award description, criteria, selection process, nature
of the award, and past recipients.
The deadline to submit nominees is DECEMBER 15, 2004.
ISPOR RESEARCH EXCELLENCE AWARDS CALL FOR NOMINATIONS
The ISPOR Awards Committee is seeking nominees for both the
ISPOR Research Excellence Award for Methodology Excellence and Research
Excellence Award for Practical Application Excellence.
See
http://www.ispor.org/awards/methodology_.asp
and
http://www.ispor.org/awards/application_.asp
for Excellence Awards descriptions, criteria, selection process, nature of
award, and past recipients.
ISPOR BERNIE O’BRIEN NEW INVESTIGATOR AWARDS CALL FOR NOMINATIONS
The ISPOR Bernie O’Brien New Investigator Award was established in 2004
to honor the long-standing commitment of Bernie J. O’Brien,
PhD to training and mentoring new scientists in the fields of outcomes research
and pharmacoeconomics. The award will be presented for the first time at the
ISPOR 10th Annual International Meeting in Washington, DC, 15-18, 2005.
The ISPOR Awards Committee is seeking nominees for this
award. See
http://www.ispor.org/awards/Obrien_investigator.asp
for descriptions, criteria, selection process, and nature of the award.
The deadline to submit nominees for both awards is
FEBRUARY 15, 2005.
HEALTH
SCIENCE INITIATIVE: RCT-CEA TASK FORCE
The
RCT-CEA final draft document is now available for all ISPOR Members to review
on our website at:
http://www.ispor.org/workpaper/RCT_CEA/RCT-CEAreport_refgroup111204.pdf.
You are invited to comment on the ISPOR Task Force document
titled: Best Practices For Economic Analysis Alongside Clinical Trials: An ISPOR
RCT-CEA Task Force Report. For information on submitting your comments please
refer to our website link at
http://www.ispor.org/surveys/research_practices/default.asp
and follow the instructions.
The
deadline for comments is December 20, 2004.
- HOT TOPICS
Top
CMS SEEKS PUBLIC COMMENT ON STANDARDIZED QUALITY MEASURES
MEASURES RECOMMENDED FOR AMBULATORY CARE AND PATIENT PERSPECTIVES
ON HOSPITAL CARE
WASINGTON
D.C. – (November 16, 2004) – Medicare is taking another important step to improve the
quality of healthcare by identifying and requesting public comment on standard
information to be used to publicly report both on how well a physician treats
certain illnesses and patient perspectives on the quality of care received
during a hospital stay.
For full
text of the article, go to:
http://www.cms.hhs.gov/media/press/release.asp?Counter=1259
- IMPORTANT DATES TO REMEMBER
Top
December 31, 2004 – Submission deadline for nominees
for ISPOR 2005 Avedis Donabedian Outcomes Research Lifetime Achievement Award.
January 10, 2005 - Abstract Submission deadline for
the ISPOR 10th Annual International Meeting.
February 2, 2005 – Submission deadline for
nominees for ISPOR 2005-2006 Board of Directors positions.
February 15, 2005 – Submission deadline for nominees
for ISPOR Research Excellence Awards and Bernie J. O’Brien New Investigator
Award.
April 19, 2005 – Early Meeting registration and hotel reservation
deadline for the ISPOR 10th Annual International Meeting, Marriott Wardman Park
Hotel, Washington, DC.
May 15-18 2005 – ISPOR 10th Annual International Meeting, Marriott Wardman Park Hotel, Washington, DC.
June 20, 2005 – Abstract Submission deadline for the ISPOR
8th Annual European Congress.
- EMPLOYMENT
Top
**NEW** 14 NEW POSITIONS
AT THE ISPOR WEBSITE:
http://www.ispor.org/employment/employment_index.asp
Advertise your positions on ISPOR Website (1 million hits
per month)
FREE
LISTING OF INTERNSHIPS
Visit ISPOR’s Internship-Professional Recruitment
Assistance Program (I-PRAP) at
http://www.ispor.org/iprap/index.asp
Over 60 student resumes
posted! I-PRAP is an ONLINE, FREE service available to ISPOR members.
STUDENTS have the opportunity to
search for internship positions available and post their CVs/resumes for
employers to view.
EMPLOYERS have the opportunity to
post their Intern positions available and access CVs/resumes from interested students.
Any questions, please contact:
iprap@ispor.org.
**NEW**Statistical Scientist – Outcomes
Research (Associate Director) With Pfizer
Position Available
Statistical Scientist – Outcomes Research (Associate
Director)
Imagine a career that touches the lives of people
everywhere. Imagine an opportunity to reach beyond your area of expertise to
make an impact on something greater than the bottom line. Imagine playing a
key role in some of the most critical issues facing healthcare today. This is
your career at Pfizer – a career unlike any other.
Partner with our Outcomes Research (OR) scientists to
develop effective OR product support programs that make
optimal use of available data sources and statistical methods.
Your contributions will provide technical statistical
support to outcomes research projects and ensure sound statistical input to the
development of health outcomes measurements, preparation of statistical
analysis plans, interpretation of statistical results, and production of
reporting displays for outcomes research projects. You will also ensure that
sound statistical principles are applied in Exploratory Data Analysis, data
mining and meta-analysis of health outcomes databases. This is an excellent
opportunity to collaborate with Outcomes Research scientists and Biostatistics
Therapeutic Area Heads to identify opportunities for exploratory analyses and
data mining of health outcomes databases. You will be expected to both
communicate and collaborate with clinical project statisticians within the
therapeutic areas to ensure consistency of statistical approaches and alignment
of statistical analyses of health outcomes with overall product marketing
strategy.
Pfizer is committed to equal opportunity in the terms and
conditions of employment for all employees and job applicants without regard to
race, color, religion, sex, sexual orientation, age, gender identity or gender
expression, national origin, disability or veteran status. Pfizer also
complies with all applicable national, state and local laws governing
nondiscrimination in employment.
For more details and to open the dialogue for consideration
please go to
www.pfizer.com/careers
and apply to requisition 039670.
- ISPOR
MEMBERSHIP
Top
Update your email address at
https://www.ispor.org/members/addresschange.asp!
Your email address is required as part of your log in information in the
members only section of the ISPOR website.
